Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats

Human and Experimental Toxicology

Volumn 33, Issue 8, 2014, Pages 800-813

  Imbaby, S ^a   Ewais, M ^a   Essawy, S ^a   Farag, N ^b  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b Suez Canal University   (Egypt)

Author keywords

Cardiac toxicity; curcumin; DOX; nebivolol; nitric oxide; oxidative stress

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; CURCUMIN; DOXORUBICIN; GLUTATHIONE PEROXIDASE; ISOPRENALINE; MITOCHONDRIAL DNA; NEBIVOLOL; SUPEROXIDE DISMUTASE; TROPONIN I; ANTIOXIDANT; MALONALDEHYDE; BENZOPYRAN DERIVATIVE; BIOLOGICAL MARKER; CARDIOTONIC AGENT; ETHANOLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CARDIOTOXICITY; CHRONOTROPISM; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOXORUBICIN INDUCED CARDIAC TOXICITY; DRUG EFFECT; DRUG INDUCED DISEASE; ELECTROCARDIOGRAM; ENZYME ACTIVITY; HEART INDEX; HEART PROTECTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; INOTROPISM; LOW DRUG DOSE; MALE; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; Q WAVE; QRS COMPLEX; QUALITY OF LIFE; RAT; ST SEGMENT; SURVIVAL RATE; TISSUE HOMOGENATE; ANTIOXIDANT ACTIVITY; HEART MUSCLE CELL; LIPID PEROXIDATION; PR INTERVAL; SINUS TACHYCARDIA; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; T WAVE; ANIMAL; CELL PROTECTION; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISEASE MODEL; DNA FRAGMENTATION; DRUG COMBINATION; DRUG EFFECTS; HEART CONTRACTION; HEART DISEASES; HEART RATE; HEART VENTRICLE FUNCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIME; WISTAR RAT;

RATTUS;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BENZOPYRANS; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CURCUMIN; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DNA, MITOCHONDRIAL; DOXORUBICIN; DRUG THERAPY, COMBINATION; ETHANOLAMINES; HEART DISEASES; HEART RATE; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS, WISTAR; TIME FACTORS; VENTRICULAR FUNCTION;

EID: 84904728714     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327114527628     Document Type: Article

References (55)

1. Stebbing J, Jones A, Barrett-Lee P. Cardiotoxicity and anthracyclines. Breast Canc Res Treat. 2008 ; 107: 451-453
2. Jensen BV, Skovsgaard T, Nielsen SI. Functional monitoring of anthracycline cardiotoxicity: a prospective blinded long term observational study of outcome in 120 patients. Ann Oncol. 2002 ; 13: 699-709
3. Bagchi D, Sen CK, Ray SD, et al. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res. 2003 ;: 523 87-524 97
4. Swamy AV, Gulliaya S, Thippeswamy A, et al. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J Pharmacol. 2012 ; 44: 73-77
5. Peng X, Chen B, Lim CC, et al. The cardiotoxicology of anthracycline chemotherapeutics: translating molecular mechanism into preventative medicine. Mol Interv. 2005 ; 5: 163-171
6. Srivastav G, Mehta JL. Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol. 2009 ; 14: 22-27
7. Mohamad RH, El-Bastawesy AM, Zekry ZK, et al. The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. J Med Food. 2009 ; 12: 394-402
8. Dayton A, Selvendiran K, Meduru S, Khan M, et al. Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function compound, HO-3867. J Pharmacol Exp Ther. 2011 ; 339: 350-357
9. Maffei A, Di Pardo A, Carangi R, et al. Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation. Am J Hyperten. 2007 ; 50: 652-656
10. de Nigris F, Rienzo M, Schiano C, et al. Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart. Eur J Canc. 2008 ; 44: 334-340
11. Kalay N, Basar E, Ozdogru I, et al. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol. 2006 ; 48: 2258-2262
12. Injac R, Strukelj B. Recent advances in protection against doxorubicin-induced toxicity. Technol Canc Res Treat. 2008 ; 7: 497-516
13. Venkatesan N. Curcumin attenuation of acute Adriamycin myocardial toxicity in rats. Br J Pharm. 1998 ; 12: 425-427
14. Toprak O, Cirit M, Tanrisev M, et al. Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol Dial Transplant. 2008 ; 23: 853-859
15. Walker MJ, Curtis MJ, Hearse DJ, et al. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction and reperfusion. Cardiovasc Res. 1988 ; 22: 447-455
16. Molina-Molina M, Pereda J, Xaubet A. Experimental models for the study of pulmonary fibrosis: current usefulness and future promise. Arch Bronconeumol. 2007 ; 43: 501-507
17. Skrzypiec-Spring M, Grotthus B, Szelag A, et al. Isolated heart perfusion according to Langendorff - -still viable in the new millennium. J Pharmacol Toxicol Method. 2007 ; 55: 113-126
18. Layland J, Mei Li J, Shah AM. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J Physiol. 2002 ; 540: 457-467
19. Rosalki SB. Quantitative determination of creatine phosphokinase (CPK) in Plasma. J Lab Clin Chem. 1977 ; 23: 646-650
20. Würzburg U, Hennrich N, Lang H. Determination of creatine kinase-MB in serum using inhibiting antibodies. Klin Wochenschr. 1976 ; 54: 357-360
21. Preuss H, Jarrel S, Scheckenobach R, et al. Comparative effects of chromium vanadium and Gymnema sylvestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr. 1998 ; 17: 116-123
22. Paglia DE, Valentin N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967 ; 70: 158-169
23. Marklund SL Handbook of methods for oxygen radical research. Greenwald RA, ed. Boca Raton, FL: CRC Press ; 1985: 243-247.
24. Green LC, Wagner DA, Gloowski J, et al. Analysis of nitrite, nitrate and [15 N] nitrite in biological fluids. Anal Biochem. 1982 ; 126: 131-138
25. Gray GM, Yardley HJ. Mitochondria and nuclei of pig and human epidermis: isolation and lipid composition. J Invest Dermatol. 1975 ; 64: 423-430
26. Chang BJ, Nishikawa M, Sato E, et al. Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys. 2002 ; 405: 55-64
27. Sambrook J, Maniatis T, Fritsch FF Molecular cloning: a laboratory manual. 3 rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press ; 2001 :
28. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998 ; 339: 900-905
29. Katz M Study design and statistical analysis: a practical guide for clinicians. London, UK: Cambridge University Press ; 2006: 155.
30. Hayward R, Hydock DS. Doxorubicin cardiotoxicity in the rat: an in vivo characterization. J Am Assoc Lab Anim Sci. 2007 ; 46: 20-32
31. Li W, Xu B, Xu J, et al. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress. Basic Clin Pharmacol Toxicol. 2009 ; 104: 192-197
32. Bakris G. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade. J Cardiovasc Pharmacol. 2009 ; 53: 379-387
33. Yee KC, Mukherjee D, Smith DE, et al. Prognostic significance of an elevated creatine kinase in the absence of an elevated troponin I during an acute coronary syndrome. Am J Cardiol. 2003 ; 92: 1442-1444
34. Potluri S, Ventura HO, Mulumudi M, et al. Cardiac troponin levels in heart failure. Cardiol Rev. 2004 ; 12: 21-25
35. Hamza A, Amin A, Daoud S. The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol Toxicol. 2008 ; 24: 63-73
36. Dbrowska K, Stuss M, Gromadzin-ska J, et al. The effects of melatonin on glutathione peroxidase activity in serum and erythrocytes after adriamycin in normal and pinealectomised rats. Endokrinol Pol. 2008 ; 59: 200-206
37. De Beer EL, Bottone AE, Voest EE. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur J Pharmacol. 2001 ; 415: 1-11
38. Choi EH, Lee N, Kim HJ, et al. Schisandra fructus extract ameliorates doxorubicin-induce cytotoxicity in cardiomyocytes: altered gene expression for detoxification enzymes. Genes Nutr. 2008 ; 2: 337-345
39. Wang GY, Wang YM, Zhang LN, et al. Effect of resveratrol on heart function of rats with adriamycin Failure. Zhongguo Zhong Yao Za Zhi. 2007 ; 32: 1563-1565
40. Kavazis AN, Smuder AJ, Min K, et al. Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72. Am J Physiol Heart Circ Physiol. 2010 ; 299: H1515 - H1524
41. Ashour AE, Sayed-Ahmed MM, Abd-Allah AR, et al. Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats. Oxid Med Cell Longe. 2012 ; 22012: 434195
42. Zhang S, Liu X, Bawa-Khalfe T, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012 ; 18: 1639-1642
43. Berthiaume JM, WallaceK B. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol. 2007 ; 23: 15-25
44. Tokarska-Schlattner M, Wallimann T, Schlattner U. Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin. C R Biol. 2006 ; 329: 657-668
45. Bai P, Mabley JG, Liaudet L, et al. Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity. Oncol Rep. 2004 ; 11: 505-508
46. Mohanty I, Arya DS, Gupta SK. Effect of Curcuma longa and Ocimum sanctum on myocardial apoptosis in experimentally induced myocardial ischemic-reperfusion injury. BMC Complement Altern Med. 2006 ; 6: 3
47. Ben P, Liu J, Lu C, et al. Curcumin promotes degradation of inducible nitric oxide synthase and suppresses its enzyme activity in RAW 264.7 cells. Int Immunopharmacol. 2011 ; 11: 179-186
48. Jomova K, Jenisova Z, Feszterova M, et al. Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol. 2011 ; 1: 95-107
49. Roy M, Sinha D, Mukherjee S, et al. Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic exposed human population in West Bengal, India. Eur J Canc Prev. 2011 ; 20: 123-131
50. Hatcher H, Planalp R, Cho J, et al. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008 ; 65: 1631-1652
51. Brixius K, Bundkirchen A, Bölck B, et al. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium. Br J Pharmacol. 2001 ; 133: 1330-1338
52. Münzel T, Gori T. Nebivolol: the somewhat-different beta-adrenergic receptor blocker. J Am Coll Cardiol. 2009 ; 54: 1491-1499
53. Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov. 2007 ; 6: 662-680
54. Lacza Z, Pankotai E, Csordás A, et al. Mitochondrial NO and reactive nitrogen species production: does mtNOS exist?. Nitric Oxide. 2006 ; 14: 162-168
55. Uzar E, Acar A, Evliyaolu O, et al. The anti-oxidant and anti-apoptotic effects of nebivolol and zofenopril in a model of cerebral ischemia/reperfusion in rats. Prog Neuropsychopharmacol Biol Psychiat. 2012 ; 36: 22-28